Christina Ornauer: Exploring the Latest Advances in Hematology at EHA 2026
Christina Ornauer, Vice President, Head of Medical Affairs of Hematology Europe at Avanzanite Bioscience, shared a post on LinkedIn:
“Attending EHA 2026 was truly inspiring, as I connected with dedicated colleagues, researchers, and healthcare professionals focused on advancing patient care.
The congress showcased the remarkable pace of innovation in hematology and emphasized the importance of collaboration within the healthcare community.
I am grateful for the opportunity to learn, exchange perspectives, and bring new insights back to my work.
Thank you to everyone who shared their expertise and passion throughout the meeting.
I look forward to seeing how these advances continue to shape the future for patients.”
Stay updated with Hemostasis Today.
-
Jun 15, 2026, 13:51Miguel Gómez Álvarez: Navigating the Complexities of Erythrocytosis and the Role of PIEZO1
-
Jun 15, 2026, 13:37Katja Sockel: EHA 2026 Inspires New Ideas and Global Connections
-
Jun 15, 2026, 13:25Srishti Goyal։ India’s Blood Donation Journey – Looking Beyond the Numbers
-
Jun 15, 2026, 13:22Debra BenAvram: Every Two Seconds – Someone Needs Blood
-
Jun 15, 2026, 13:05Angelo Zanniti: Back from EHA 2026 Congress
-
Jun 15, 2026, 12:56Chiara Pirillo: Building Global Connections at EHA 2026
-
Jun 15, 2026, 12:50Marina Planas: MRD and Molecular Monitoring Take Center Stage at EHA 2026
-
Jun 15, 2026, 12:46Moonmoon Kazi: Climb Bio Presents Phase 1b ITP Trial Data at EHA 2026
-
Jun 15, 2026, 12:44Wolfgang Miesbach: Base Editing and the Future of Sickle Cell Disease Therapy